Clinical Trials Browser

anlotinib × Sarcoma × 90 days × Clear all

NCT07612098 2026-05-28

SPARE-04

Phase 2 Not yet recruiting

Sarcoma

NCT05301764 2026-05-20

A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

Phase 1/2 Completed

Sarcoma